HPV vaccination in the UK
- PMID: 18436916
- PMCID: PMC2375994
- DOI: 10.1136/bmj.39555.668229.80
HPV vaccination in the UK
Abstract
Acceptable uptake is possible in schools, but important practical barriers exist
Conflict of interest statement
Competing interests: JoW has received funding to attend a meeting from Sanofi Pasteur MSD. JaW has received consultancy funding, honorariums, and funding to attend meetings from Sanofi Pasteur MSD (manufacturer of Gardasil) and GlaxoSmithKline Biologicals (manufacturer of Cervarix).
Comment on
-
Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study.BMJ. 2008 May 10;336(7652):1056-8. doi: 10.1136/bmj.39541.534109.BE. Epub 2008 Apr 24. BMJ. 2008. PMID: 18436917 Free PMC article.
References
-
- Brabin L, Roberts SA, Stretch R, Baxter D, Chambers G, Kitchener H, et al. Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. BMJ 2008; doi: 10.1136/bmj.39541.534109.BE - DOI - PMC - PubMed
-
- Brabin L, Roberts SA, Farzaneh F, Kitchener HC. Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine 2006;24:3087-94. - PubMed
-
- Marlow LA, Waller J, Wardle J. Parental attitudes to pre-pubertal HPV vaccination. Vaccine 2007;25:1945-52. - PubMed
-
- Zimet GD, Shew ML, Kahn JA. Appropriate use of cervical cancer vaccine. Annu Rev Med 2008;59:223-36. - PubMed
-
- Trotter CL, Ramsay EB, Kaczmarski EB. Meningococcal serogroup C conjugate vaccination in England and Wales: coverage and initial impact of the campaign. Commun Dis Public Health 2002;5:220-5. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources